Optimization of norbornyl-based carbocyclic nucleoside analogs as cyclin-dependent kinase 2 inhibitors

KÖPRÜLÜOGLU, C., DEJMEK, M., ŠÁLA, M., AJANI, H., HŘEBABECKÝ, H., FANFRLÍK, J., JORDA, R., DRAČÍNSKÝ, M., PROCHÁZKOVÁ, E., ŠÁCHA, P., KRYŠTOF, V., HOBZA, P., LEPŠÍK, M., NENCKA, R. Optimization of norbornyl-based carbocyclic nucleoside analogs as cyclin-dependent kinase 2 inhibitors. Journal of Molecular Recognition. 2020, 33(8), e2842. ISSN 0952-3499. E-ISSN 1099-1352. Available: doi: 10.1002/jmr.2842.